» Articles » PMID: 28755158

Optimizing Endothelial Cell Functionalization for Cell Therapy of Vascular Proliferative Disease Using a Direct Contact Co-culture System

Overview
Publisher Springer
Specialty Pharmacology
Date 2017 Jul 30
PMID 28755158
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Increased susceptibility to thrombosis, neoatherosclerosis, and restenosis due to incomplete regrowth of the protective endothelial layer remains a critical limitation of the interventional strategies currently used clinically to relieve atherosclerotic obstruction. Rapid recovery of endothelium holds promise for both preventing the thrombotic events and reducing post-angioplasty restenosis, providing the rationale for developing cell delivery strategies for accelerating arterial reendothelialization. The successful translation of experimental cell therapies into clinically viable treatment modalities for restoring vascular endothelium critically depends on identifying strategies for enhancing the functionality of endothelial cells (EC) derived from high cardiovascular risk patients, the target group for the majority of angioplasty procedures. Enhancing EC-associated nitric oxide (NO) synthesis by inducing overexpression of NO synthase (NOS) has shown promise as a way of increasing paracrine activity and restoring function of EC. In the present study, we developed a direct contact co-culture approach compatible with highly labile effectors, such as NO, and applied it for determining the effect of EC functionalization via NOS gene transfer on the growth of co-cultured arterial smooth muscle cells (A10 cell line) exhibiting the defining characteristics of neointimal cells. Bovine aortic endothelial cells magnetically transduced with inducible NOS-encoding adenovirus (Ad) formulated in zinc oleate-based magnetic nanoparticles (MNP[Ad]) strongly suppressed growth of proliferating A10 and attenuated the stimulatory effect of a potent mitogen, platelet-derived growth factor (PDGF-BB), whereas EC functionalization with free Ad or MNP formulated with a different isoform of the enzyme, endothelial NOS, was associated with lower levels of NO synthesis and less pronounced antiproliferative activity toward co-cultured A10 cells. These results show feasibility of applying magnetically facilitated gene transfer to potentiate therapeutically relevant effects of EC for targeted cell therapy of restenosis. The direct contact co-culture methodology provides a sensitive and reliable tool with potential utility for a variety of biomedical applications.

Citing Articles

Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells.

Battig M, Alferiev I, Guerrero D, Fishbein I, Pressly B, Levy R ACS Appl Bio Mater. 2020; 3(6):3914-3922.

PMID: 33251488 PMC: 7687866. DOI: 10.1021/acsabm.0c00466.


Cardiovascular delivery of drugs and biotherapeutics.

Chorny M, Levy R, Golomb G Drug Deliv Transl Res. 2018; 8(4):865-867.

PMID: 29359245 DOI: 10.1007/s13346-018-0483-y.

References
1.
Chorny M, Fishbein I, Yellen B, Alferiev I, Bakay M, Ganta S . Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A. 2010; 107(18):8346-51. PMC: 2889533. DOI: 10.1073/pnas.0909506107. View

2.
Adamo R, Fishbein I, Zhang K, Wen J, Levy R, Alferiev I . Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries. J Control Release. 2015; 222:169-75. PMC: 4718792. DOI: 10.1016/j.jconrel.2015.12.025. View

3.
Hofmann A, Wenzel D, Becher U, Freitag D, Klein A, Eberbeck D . Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A. 2009; 106(1):44-9. PMC: 2629186. DOI: 10.1073/pnas.0803746106. View

4.
Steinberg D, Gaglia Jr M, Pinto Slottow T, Roy P, Bonello L, De Labriolle A . Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009; 103(4):491-5. DOI: 10.1016/j.amjcard.2008.09.107. View

5.
Lemos P . To heal without renarrowing: is it possible to make it real?. Catheter Cardiovasc Interv. 2007; 70(5):661. DOI: 10.1002/ccd.21388. View